Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Plasma and whole-body turnover studies of human C-reactive protein (CRP), isolated from a single normal healthy donor and labeled with 125I, were undertaken in 8 healthy control subjects and 35 hospitalized patients including cases of rheumatoid arthritis, systemic lupus erythematosus, infections, and neoplasia. Plasma clearance of 125I-CRP closely approximated to a monoexponential function and was similar in the control and all patient groups. There was no evidence for accelerated clearance or catabolism of CRP in any of the diseases studied. The 19-h half-life was more rapid than that of most human plasma proteins studied previously, and the fractional catabolic rate was independent of the plasma CRP concentration. The synthesis rate of CRP is thus the only significant determinant of its plasma level, confirming the validity of serum CRP measurement as an objective index of disease activity in disorders associated with an acute-phase response. Approximately 90% of injected radioactivity was recovered in the urine after 7 d, and scintigraphic imaging studies with 123I-labeled CRP in 10 patients with different focal pathology showed no significant localization of tracer. The functions of CRP are thus likely to be effected predominantly in the fluid phase rather than by major deposition at sites of tissue damage or inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Pepys, M. B., & Baltz, M. L. (1983) · Advances in Immunology · doi:10.1016/s0065-2776(08)60379-x · Cited by 1,272
Self-citationC-REACTIVE PROTEIN FIFTY YEARS ON
Pepys, M. B. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91565-8 · Cited by 681
Self-citationKaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Evaluation of Systemic Amyloidosis by Scintigraphy with123I-Labeled Serum Amyloid P Component
Hawkins, P. N., Lavender, J. P., & Pepys, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230803 · Cited by 533
Self-citationSolid phase radioimmunoassays for human C-reactive protein
Shine, B., de Beer, F. C., & Pepys, M. B. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90005-x · Cited by 319
Self-citationSerum levels of C‐reactive protein in Crohn's disease and ulcerative colitis
FAGAN, E. A., DYCK, R. F., MATON, P. N., HODGSON, H. J. F., CHADWICK, V. S., PETRIE, A., & PEPYS, M. B. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb02244.x · Cited by 311
Self-citationCOMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES*
Volanakis, J. E. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22140.x · Cited by 278
McDougal, J. S., Martin, L. S., Cort, S. P., Mozen, M., Heldebrant, C. M., & Evatt, B. L. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112045 · Cited by 255
C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
Mold, C., Nakayama, S., Holzer, T. J., Gewurz, H., & Du Clos, T. W. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.5.1703 · Cited by 244
Cited by
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
Self-citationC-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Self-citationRole of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Self-citationProduction of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Steptoe, A., Hamer, M., & Chida, Y. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.03.011 · Cited by 1,278
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Regan, M. M., Price, N. J., Dinges, D. F., & Mullington, J. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.050 · Cited by 1,195
“C-reactive protein (CRP) is a pentameric hepatocyte protein with a half-life of 15 to 19 h ( 11 ) and is the major marker of the “acute-phase response,” or the formation of plasma proteins in response to an inflammatory stimulus, in humans (12).”
BackgroundThe physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818
“CRP binds only to damaged plasma membranes, in which there is an increased proportion of lysophospholipid, and can then activate complement, presumably to promote beneficial and scavenging functions, but also possibly to enhance tissue injury [36–39].”
BackgroundMethodSelf-citationMacy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797
Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation
Mullington, J. M., Haack, M., Toth, M., Serrador, J. M., & Meier-Ewert, H. K. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.10.003 · Cited by 783
“While IL-6 is predictive of the development of cardiovascular disease (46), CRP has an advantage in that it is more stable, with a much longer half-life (47); and is without diurnal rhythm (48).”
BackgroundMorrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., & Braunwald, E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00136-3 · Cited by 782
Elevated Levels of Interleukin-6 in Unstable Angina
Biasucci, L. M., Vitelli, A., Liuzzo, G., Altamura, S., Caligiuri, G., Monaco, C., Rebuzzi, A. G., Ciliberto, G., & Maseri, A. (1996) · Circulation · doi:10.1161/01.cir.94.5.874 · Cited by 738
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Allin, K. H., & Nordestgaard, B. G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.599831 · Cited by 553
Mullington, J. M., Simpson, N. S., Meier-Ewert, H. K., & Haack, M. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.08.014 · Cited by 519
“HsCRP is not the only inflammatory marker of risk in CVD currently available; however, it is arguably the most clinically useful because it is relatively stable across weeks and months (32), has a long half-life of 15–19 hours (33), does not show a diurnal rhythm (34), and there is a growing body of normative data ava…”
BackgroundGriselli, M., Herbert, J., Hutchinson, W. L., Taylor, K. M., Sohail, M., Krausz, T., & Pepys, M. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1733 · Cited by 508
Self-citationHigh-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 494
Tennent, G. A., Lovat, L. B., & Pepys, M. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4299 · Cited by 438
Self-citationHofer, N., Zacharias, E., Müller, W., & Resch, B. (2012) · Neonatology · doi:10.1159/000336629 · Cited by 427
Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery
Faraut, B., Boudjeltia, K. Z., Vanhamme, L., & Kerkhofs, M. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.05.001 · Cited by 418
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Price, N., Dinges, D. F., & Mullington, J. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.426 · Cited by 410
“... the appearance of CRP in plasma have shown that increased concentrations in response to exogenous IL-6 administration occur ;6 ‐12 h after IL-6 challenge (30, 31 ). This is consistent with data on the increase of CRP after acute myocardial infarction (32 ) .A single study has examined the half-life of the disappea…”
ResultC-reactive protein: a valuable marker of sepsis
Póvoa, P. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1209-6 · Cited by 403
Arici, M., & Walls, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002407.x · Cited by 398
C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction
Lagrand, W. K., Niessen, H. W. M., Wolbink, G.-J., Jaspars, L. H., Visser, C. A., Verheugt, F. W. A., Meijer, C. J. L. M., & Hack, C. E. (1997) · Circulation · doi:10.1161/01.cir.95.1.97 · Cited by 388
C‐reactive protein and coronary heart disease: a critical review
Casas, J. P., Shah, T., Hingorani, A. D., Danesh, J., & Pepys, M. B. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02015.x · Cited by 366
Self-citationThree dimensional structure of human C-reactive protein
Shrive, A. K., Gheetham, G. M. T., Holden, D., Myles, D. A. A., Turnell, W. G., Volanakis, J. E., Pepys, M. B., Bloomer, A. C., & Greenhough, T. J. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0496-346 · Cited by 356
Self-citationC-reactive protein as a marker of infection in critically ill patients
Póvoa, P., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P., & Sabino, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01044.x · Cited by 346
Structure and function of the pentraxins
Gewurz, H., Zhang, X.-H., & Lint, T. F. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80029-8 · Cited by 328
C-Reactive Protein in Atherothrombosis and Angiogenesis
Badimon, L., Peña, E., Arderiu, G., Padró, T., Slevin, M., Vilahur, G., & Chiva-Blanch, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00430 · Cited by 323
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
Slaats, J., ten Oever, J., van de Veerdonk, F. L., & Netea, M. G. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005973 · Cited by 317
C-reactive protein as an indicator of sepsis
Póvoa, P., Almeida, E., Moreira, P., Fernandes, A., Mealha, R., Aragão, A., & Sabino, H. (1998) · Intensive Care Medicine · doi:10.1007/s001340050715 · Cited by 312
Caliezi, C., Wuillemin, W. A., Zeerleder, S., Redondo, M., Eisele, B., & Hack, C. E. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01437-6 · Cited by 312
Schalkwijk, C. G., Poland, D. C. W., van Dijk, W., Kok, A., Emeis, J. J., Dräger, A. M., Doni, A., van Hinsbergh, V. W. M., & Stehouwer, C. D. A. (1999) · Diabetologia · doi:10.1007/s001250051162 · Cited by 309
Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02970-x · Cited by 300
Diagnostic markers of infection in neonates
Ng, P. C. (2004) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2002.023838 · Cited by 298
C-reactive protein and inflammation: conformational changes affect function
Wu, Y., Potempa, L. A., El Kebir, D., & Filep, J. G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0149 · Cited by 285
C-reactive protein and cardiovascular disease: new insights from an old molecule
Hirschfield, G. M., & Pepys, M. B. (2003) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcg134 · Cited by 251
“This is because the plasma half-life of CRP is the same (about 19 h) under all conditions, and the sole determinant of the plasma concentration is therefore the synthesis rate, which, in turn, reflects the intensity of the pathological process(es) stimulating CRP production.(12) In vivo turnover studies of human CRP i…”
BackgroundSelf-citationThe acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients
Kaysen, G. A., Dubin, J. A., Müller, H. G., Rosales, L. M., & Levin, N. W. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00172.x · Cited by 219
“The half-lives of cytokines and of the APPs are quite short, and their total body masses are quite small in comparison to that of albumi”
BackgroundRidker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206
Biomarkers in inflammatory bowel disease: current practices and recent advances.
Iskandar, H. N., & Ciorba, M. A. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.001 · Cited by 210
“(17) Positive features for CRP as a biomarker include that it is easily and reliably measured across diagnostic laboratories and has a short plasma half-life of ~19 hours which is determined by synthesis rather than degradation.(18)”
BackgroundKaysen, G. A., Chertow, G. M., Adhikarla, R., Young, B., Ronco, C., & Levin, N. W. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00804.x · Cited by 210
“The reason for this is the much larger range in available values for the major acute phase proteins, such as CRP, and the much shorter half-live”
BackgroundEffect of high-dose intravenous vitamin C on inflammation in cancer patients
Mikirova, N., Casciari, J., Rogers, A., & Taylor, P. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-189 · Cited by 193
“It correlates with disease progression and can be used to monitor infection [18,24-27].”
BackgroundNewer approaches to the diagnosis of early onset neonatal sepsis: Table 1
Mishra, U. K., Jacobs, S. E., Doyle, L. W., & Garland, S. M. (2006) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2004.064188 · Cited by 185
Schmit, X., & Vincent, J. L. (2008) · Infection · doi:10.1007/s15010-007-7077-9 · Cited by 165
“Once the source of infection is identified and adequately treated, CRP concentrations fall rapidly as it has a half-life of 19 hours [ 7 ].”
BackgroundThe role of C-reactive protein as an inflammatory marker in gastrointestinal diseases
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0359 · Cited by 149
“infection, inflammation, trauma, childbirth, severe burns, stress and neoplasia), however, the liver has a large capacity to increase the baseline production of CRP by upregulating its transcription in hepatocytes”
BackgroundComplement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90
Self-citationBlum, S., Aviram, M., Ben-Amotz, A., & Levy, Y. (2006) · Annals of Nutrition and Metabolism · doi:10.1159/000089560 · Cited by 73
“Another high-fat meal (milkshake) postprandial study was performed in 11 obese men comparing fish oil or placebo to weight reduction. CRP decreased by 0.7p and 6.6p after 2 and 4 h, respectively [ ,”
BackgroundHuman Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum
Hutchinson, W. L., Hohenester, E., & Pepys, M. B. (2000) · Molecular Medicine · doi:10.1007/bf03401789 · Cited by 66
“The protomers of human CRP are non-glycosylated and have an Mr of 23,027, as predicted by the amino acid sequence and confirmed by ESIMS measurement (44).”
MethodSelf-citationLi, H.-Y., Tang, Z.-M., Wang, Z., Lv, J.-M., Liu, X.-L., Liang, Y.-L., Cheng, B., Gao, N., Ji, S.-R., & Wu, Y. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.003 · Cited by 39
The relationship between inflammatory state and quantity of affective episodes in bipolar disorder
Queissner, R., Pilz, R., Dalkner, N., Birner, A., Bengesser, S. A., Platzer, M., Fellendorf, F. T., Kainzbauer, N., Herzog-Eberhard, S., Hamm, C., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.024 · Cited by 35
C-reactive protein and the acute phase reaction in geriatric patients
Bertsch, T., Triebel, J., Bollheimer, C., Christ, M., Sieber, C., Fassbender, K., & Heppner, H. J. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0938-4 · Cited by 24
Metadata
- Authors
- Vigushin, D. M., Pepys, M. B., & Hawkins, P. N.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-04-01
- Volume
- 91
- Issue
- 4
- Pages
- 1351-1357
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2011092724
- Cited by
- 636
- References
- 39
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.